Top Page
Eurocell
(LSE:ECEL)
Eurocell (ECEL) vs. iShares MSCI United Kingdom ETF (EWC)
Eurocell Business Overview & Revenue Model
Eurocell Earnings Call Summary
Eurocell Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 375.40M | 357.90M | 364.50M | 381.20M | 339.80M | 257.90M |
| Gross Profit | 193.90M | 188.30M | 173.80M | 182.70M | 170.20M | 125.80M |
| EBITDA | 32.10M | 41.90M | 39.60M | 53.00M | 52.40M | 21.10M |
| Net Income | 7.60M | 10.50M | 9.60M | 19.70M | 21.10M | -2.20M |
Balance Sheet | ||||||
| Total Assets | 292.20M | 223.80M | 223.80M | 254.90M | 240.20M | 201.40M |
| Cash, Cash Equivalents and Short-Term Investments | 6.40M | 400.00K | 400.00K | 5.10M | 6.60M | 7.10M |
| Total Debt | 116.80M | 62.90M | 58.60M | 84.00M | 76.30M | 65.40M |
| Total Liabilities | 188.90M | 118.40M | 109.50M | 140.00M | 134.00M | 114.20M |
| Stockholders Equity | 103.30M | 105.40M | 114.30M | 114.90M | 106.20M | 87.20M |
Cash Flow | ||||||
| Free Cash Flow | 28.40M | 33.90M | 43.70M | 21.50M | 13.50M | 18.20M |
| Operating Cash Flow | 40.50M | 44.20M | 52.80M | 33.90M | 29.00M | 32.20M |
| Investing Cash Flow | -32.50M | -10.30M | -8.30M | -12.10M | -15.50M | -14.00M |
| Financing Cash Flow | -2.40M | -36.90M | -49.20M | -17.40M | -15.40M | -20.50M |
Eurocell Technical Analysis
Eurocell Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ― | ― | 16.23% | 4.27% | 4.67% | 93.06% | |
74 Outperform | £274.34M | 21.68 | 10.01% | 3.48% | -3.93% | 41.83% | |
71 Outperform | £806.64M | 16.43 | 7.68% | 3.21% | 5.88% | 107.36% | |
70 Neutral | £128.83M | 17.43 | 7.23% | 4.02% | 5.51% | -33.75% | |
66 Neutral | £85.86M | 9.03 | ― | 1.49% | 19.86% | 19.09% | |
65 Neutral | £192.30M | 38.13 | 9.50% | 4.39% | -3.51% | -67.38% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
Eurocell Corporate Events
Eurocell plc, a company involved in the manufacturing and distribution sector, has announced a share buyback transaction. The company purchased 9,182 of its ordinary shares at a price of 124.76 pence per share, resulting in a total issued share capital of 99,860,021 shares. This move is part of Eurocell’s strategy to manage its capital structure and may impact shareholder voting rights and interest notifications under regulatory rules.
Eurocell plc has executed a share buyback program, purchasing 9,446 of its ordinary shares at a price of 127.50 pence each on the London Stock Exchange. This transaction adjusts the company’s issued share capital to 99,869,203 shares, impacting the total number of voting rights and potentially influencing shareholder notifications under regulatory rules.
Eurocell plc has announced that it has recommended the purchase of 675,000 ordinary shares by the Eurocell Employee Benefit Trust to benefit the company’s employees. This move is aimed at supporting current and future share schemes, enhancing employee engagement and potentially strengthening the company’s market position.
Eurocell plc has executed a share buyback program, purchasing 10,015 of its ordinary shares at a consistent price of 126 pence per share. This transaction, conducted through Berenberg, results in Eurocell having an issued share capital of 99,878,649 shares, which impacts shareholder voting rights and aligns with regulatory transparency requirements.
Eurocell plc has executed a share buyback program, purchasing 9,872 of its ordinary shares at a price of 123.50 pence each on the London Stock Exchange. This transaction adjusts the company’s issued share capital to 99,888,664 shares, impacting shareholder voting rights and reflecting the company’s strategic financial management.
Eurocell plc, a company involved in the manufacturing and distribution of building products, has announced a transaction involving the repurchase of its own shares. The company has bought back 11,570 ordinary shares at a price of 120 pence each, resulting in a total issued share capital of 99,909,215 shares. This move is part of Eurocell’s Share Buyback Programme, which could impact the company’s market positioning by potentially increasing shareholder value and adjusting the number of voting rights.
Eurocell plc has executed a share buyback program, purchasing 12,111 of its ordinary shares at a price of 119.90 pence each on the London Stock Exchange. This transaction reduces the company’s issued share capital to 99,920,785 shares, impacting the total number of voting rights and potentially influencing shareholder calculations under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 12,520 of its ordinary shares at a consistent price of 118.83 pence per share on the London Stock Exchange. This transaction adjusts the company’s issued share capital to 99,932,896 shares, impacting shareholder calculations under the Financial Conduct Authority’s rules.
Eurocell plc, a company listed on the London Stock Exchange, announced a share buyback transaction where it purchased 12,671 of its ordinary shares at a price of 119 pence each. This transaction is part of the company’s Share Buyback Programme, and following the purchase, Eurocell’s issued share capital consists of 99,945,416 shares, which is also the total number of voting rights in the company. This move may impact shareholder calculations regarding their interests under the Financial Conduct Authority’s Disclosure and Transparency Rules.
Eurocell plc has announced a transaction involving the repurchase of its own shares, executed through Berenberg, the company’s broker. The company purchased 12,703 ordinary shares on the London Stock Exchange at a price of 118.22 pence per share. Following this transaction, Eurocell’s issued share capital consists of 99,958,087 shares, which is also the total number of voting rights. This transaction is part of Eurocell’s Share Buyback Programme and aligns with regulatory requirements, potentially impacting shareholder calculations related to interest notifications.
Eurocell plc has executed a share buyback program, purchasing 17,027 of its ordinary shares at a consistent price of 119.50 pence per share on the London Stock Exchange. This transaction reduces the company’s issued share capital to 99,970,790 shares, affecting the total number of voting rights and potentially influencing shareholder interest calculations under the Financial Conduct Authority’s rules.
Eurocell, a company listed on the London Stock Exchange, has repurchased 17,114 of its ordinary shares at a price of 120.46 pence each. This transaction, conducted through Berenberg, the company’s broker, is part of Eurocell’s Share Buyback Programme. Following this purchase, Eurocell’s issued share capital consists of 99,987,817 shares, which is also the total number of voting rights. This move may impact shareholders as they calculate their interests under the Financial Conduct Authority’s Disclosure and Transparency Rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a transaction to repurchase 16,398 of its ordinary shares at a consistent price of 126.00 pence per share. This buyback reduces the company’s treasury shares to zero and sets the total number of voting rights at 100,004,931, potentially impacting shareholder calculations under the Financial Conduct Authority’s rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 16,377 of its ordinary shares at a price of 125.20 pence per share. This transaction, conducted through Berenberg, results in the company’s issued share capital consisting of 100,021,329 shares, which shareholders can use to determine their voting rights under the Financial Conduct Authority’s rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 16,160 of its ordinary shares at a consistent price of 130 pence each. This transaction results in the company’s issued share capital consisting of 100,037,706 shares, with no shares held in treasury, thereby impacting the total number of voting rights available to shareholders.
Eurocell plc has executed a share buyback program, purchasing 16,630 of its ordinary shares at a consistent price of 132.40 pence per share on the London Stock Exchange. This transaction, facilitated by Berenberg, results in Eurocell having no shares held in treasury, with a total issued share capital of 100,053,866 shares. The buyback aligns with the company’s strategic financial management, potentially impacting shareholder value and market perception.
Eurocell plc, a company listed on the London Stock Exchange, has repurchased 16,616 of its ordinary shares at a price of 130 pence per share. This transaction, executed through Berenberg, is part of the company’s Share Buyback Programme. Following this purchase, Eurocell’s issued share capital will consist of 100,070,496 shares, which is also the total number of voting rights. This move is in line with regulatory requirements and may impact shareholder calculations regarding their interests in the company.
Eurocell plc announced a share buyback transaction, purchasing 16,405 of its ordinary shares at a consistent price of 128 pence per share. This transaction, executed through Berenberg, is part of the company’s strategy to manage its capital structure, resulting in an issued share capital of 100,087,112 shares. The buyback reflects Eurocell’s commitment to enhancing shareholder value and maintaining transparency in accordance with regulatory requirements.
Eurocell plc has executed a share buyback program, purchasing 15,881 of its ordinary shares at a consistent price of 131 pence per share on the London Stock Exchange. This transaction leaves the company with no shares held in treasury and an issued share capital of 100,103,517 shares. The move is part of a strategic effort to manage its capital structure and potentially enhance shareholder value, reflecting Eurocell’s commitment to maintaining financial health and transparency.
Eurocell plc, a company involved in the manufacturing and distribution of building materials, announced that Karen Mapp, closely associated with Derek Mapp, the Non-Executive Chair of the Board, purchased 50,000 ordinary shares at £1.28 each. This transaction increases Derek Mapp’s total shareholding to 651,444 ordinary shares, representing 0.65% of the company’s voting rights, indicating a continued confidence in the company’s prospects.
Eurocell plc, a company involved in the manufacturing and supply of building products, announced that five of its non-executive directors have purchased shares under the Non-executive Directors’ Share Purchase Plan. This move, which includes directors such as Derek Mapp and Alison Littley, reflects a commitment to align their interests with those of shareholders, potentially strengthening investor confidence and enhancing the company’s market position.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program by purchasing 15,395 of its ordinary shares at a volume-weighted average price of 127.95 pence per share. This transaction, carried out through Berenberg, the company’s broker, results in Eurocell having no shares held in treasury, with the total issued share capital now consisting of 100,119,398 shares. This move impacts the company’s voting rights, which shareholders can use to determine their interest in the company under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 15,445 of its ordinary shares at a volume-weighted average price of 125.81 pence per share on the London Stock Exchange. This transaction leaves the company with an issued share capital of 100,134,793 shares, impacting the total number of voting rights and potentially influencing shareholder interests under the Financial Conduct Authority’s rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 15,642 of its ordinary shares at a price of 126.75 pence per share. This transaction, conducted through Berenberg, results in Eurocell having no shares held in treasury and a total issued share capital of 100,150,238 shares. The buyback impacts the company’s share capital structure and provides a new denominator for shareholders to calculate their interest in accordance with the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 15,277 of its ordinary shares at a price of 125.95 pence each on the London Stock Exchange. This transaction leaves the company with an issued share capital of 100,165,880 shares, impacting the total number of voting rights and potentially influencing shareholder interest notifications under regulatory rules.
Eurocell plc has executed a share buyback program, purchasing 15,549 of its ordinary shares at a price of 127 pence each on the London Stock Exchange. This transaction leaves the company with no shares held in treasury, resulting in a total issued share capital of 100,181,157 shares, which also represents the total number of voting rights. This move is part of Eurocell’s strategy to manage its capital structure and potentially enhance shareholder value.
Eurocell plc has announced the retirement of its long-serving CFO, Michael Scott, who will be succeeded by Will Truman, a current Non-executive Director at the company. This leadership transition is expected to provide stability and continuity as Eurocell continues to execute its strategic objectives, with Truman’s extensive experience and understanding of the company being seen as valuable assets.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 14,843 of its ordinary shares at a consistent price of 127.50 pence per share. This transaction leaves Eurocell with a total issued share capital of 100,196,706 shares, which stakeholders can use to assess their voting rights and shareholding changes under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 13,971 of its ordinary shares at a consistent price of 125 pence each on the London Stock Exchange. This transaction leaves the company with an issued share capital of 100,211,549 shares, which shareholders can use to calculate their interests under the Financial Conduct Authority’s rules. This move is part of Eurocell’s strategy to manage its capital structure and potentially enhance shareholder value.
Eurocell plc has executed a share buyback program, purchasing 13,599 of its ordinary shares on the London Stock Exchange at a volume-weighted average price of 126.75 pence per share. This transaction reduces the company’s treasury shares to zero, with the total issued share capital now consisting of 100,225,520 shares, impacting shareholder voting rights and potentially influencing market perceptions of the company’s financial health.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 12,979 of its ordinary shares at a volume-weighted average price of 128.75 pence per share. This transaction leaves Eurocell with an issued share capital of 100,239,119 shares, which will serve as the basis for shareholder voting rights calculations, in line with the Financial Conduct Authority’s Disclosure and Transparency Rules.
Eurocell plc has executed a share buyback program, purchasing 15,127 of its ordinary shares at a price of 129.75 pence per share on the London Stock Exchange. This transaction reduces the company’s issued share capital to 100,252,098 shares, impacting the total number of voting rights and potentially influencing shareholder interest calculations under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 15,038 of its ordinary shares at a consistent price of 126.25 pence per share on the London Stock Exchange. This transaction results in a total issued share capital of 100,267,225 shares, impacting the company’s voting rights and potentially influencing shareholder interests under the Financial Conduct Authority’s Disclosure and Transparency Rules.
Eurocell, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 5,297 of its ordinary shares at a consistent price of 124.75 pence per share. This transaction results in Eurocell’s issued share capital consisting of 100,282,263 shares, which is relevant for shareholder voting rights and compliance with the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 5,226 of its ordinary shares at a consistent price of 123.50 pence per share on the London Stock Exchange. This transaction adjusts the company’s issued share capital to 100,287,560 shares, impacting shareholder calculations under the Financial Conduct Authority’s rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 5,451 of its ordinary shares at a price of 123 pence per share. This transaction leaves the company with an issued share capital of 100,292,786 shares and no shares held in treasury, impacting the total number of voting rights available to shareholders.
Eurocell plc has executed a share buyback, purchasing 5,551 of its ordinary shares at a consistent price of 125 pence each on the London Stock Exchange. This transaction, facilitated by Berenberg, leaves the company with no shares held in treasury and a total of 100,298,237 shares in circulation, impacting shareholders’ calculations for interest notifications under regulatory rules.
Eurocell plc has executed a share buyback program, purchasing 5,818 of its ordinary shares at a consistent price of 125.50 pence per share. This transaction, conducted through Berenberg, results in the company’s issued share capital consisting of 100,303,788 shares, with no shares held in treasury. This move is part of Eurocell’s strategic financial management, potentially impacting shareholder value and market perception.
Eurocell plc has executed a share buyback program, purchasing 5,589 of its ordinary shares at a consistent price of 125.50 pence per share. This transaction leaves the company with an issued share capital of 100,309,606 shares, which will be used by shareholders for regulatory compliance under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback, purchasing 5,787 of its ordinary shares at a consistent price of 128.50 pence per share on the London Stock Exchange. This transaction, conducted through Berenberg, results in an issued share capital of 100,315,195 shares, impacting shareholder voting rights and aligning with regulatory requirements.
Eurocell plc has executed a share buyback program, purchasing 5,769 of its ordinary shares at a price of 130.11 pence each on the London Stock Exchange. This transaction, facilitated by Berenberg, results in the company’s issued share capital consisting of 100,320,982 shares, which shareholders can use to calculate their voting rights under the Financial Conduct Authority’s rules.
Eurocell plc announced the repurchase of 5,696 of its ordinary shares on the London Stock Exchange, each at a price of 129.50 pence. This transaction is part of the company’s Share Buyback Programme and results in a total issued share capital of 100,326,751 shares, affecting the number of voting rights and potentially impacting shareholder interest notifications.
Eurocell plc, a company involved in the production and distribution of building materials, has announced a transaction involving the repurchase of its own shares. On October 10, 2025, Eurocell purchased 5,853 of its ordinary shares at a price of 128.50 pence per share on the London Stock Exchange. This transaction is part of a Share Buyback Programme, and following the purchase, the company’s issued share capital consists of 100,332,447 shares. This move impacts the total number of voting rights, which remains at 100,332,447, and is relevant for shareholders under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 5,698 of its ordinary shares at a consistent price of 126.95 pence per share. This transaction impacts the company’s capital structure, leaving it with 100,338,300 shares in circulation, which is relevant for shareholder voting rights and regulatory disclosures.
Eurocell plc has executed a share buyback program, purchasing 5,698 of its ordinary shares at a price of 126.95 pence each on the London Stock Exchange. This transaction, conducted through Berenberg, results in the company’s issued share capital consisting of 100,338,300 shares, which shareholders can use to determine their interest under the Financial Conduct Authority’s rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 10,149 of its ordinary shares at a price of 127.50 pence each. This transaction results in the company having an issued share capital of 100,343,998 shares, which is important for shareholders to calculate their voting rights under the Financial Conduct Authority’s rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 10,324 of its ordinary shares at an average price of 128.81 pence per share. This transaction leaves the company with no shares held in treasury, resulting in an issued share capital of 100,354,147 shares with equal voting rights. This move is part of Eurocell’s strategy to manage its capital structure and could impact shareholder calculations regarding their interests under the Financial Conduct Authority’s rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 10,348 of its ordinary shares at an average price of 128.77 pence per share. This transaction leaves the company with no shares held in treasury and a total issued share capital of 100,364,471 shares, which shareholders can use to assess their voting rights under the Financial Conduct Authority’s Disclosure and Transparency Rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 10,138 of its ordinary shares at a consistent price of 131 pence per share. This transaction has resulted in the company’s issued share capital consisting of 100,374,819 shares, which is relevant for shareholders calculating their interests under the Financial Conduct Authority’s rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 10,138 of its ordinary shares at a consistent price of 131 pence per share. This transaction results in the company’s issued share capital consisting of 100,374,819 shares, with no shares held in treasury. The buyback affects the total number of voting rights, which remains at 100,374,819, a figure significant for shareholders under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 11,538 of its ordinary shares at a consistent price of 134 pence each on the London Stock Exchange. This transaction, conducted through Berenberg, results in Eurocell having no shares held in treasury and a total issued share capital of 100,384,957 shares, which aligns with regulatory requirements and provides a clear denominator for shareholder voting rights calculations.
Eurocell plc has executed a share buyback, purchasing 11,613 of its ordinary shares at a consistent price of 133 pence per share on the London Stock Exchange. This transaction leaves the company with an issued share capital of 100,396,495 shares, which will be used by shareholders to determine notification requirements under the Financial Conduct Authority’s rules.
Eurocell plc, a company involved in the purchase of its own shares, has executed a transaction involving 10,954 ordinary shares at a consistent price of 130 pence per share on the London Stock Exchange. This buyback leaves the company with an issued share capital of 100,408,108 shares, which is also the total number of voting rights. This transaction is part of Eurocell’s Share Buyback Programme and adheres to the UK regulations under the Financial Conduct Authority’s Disclosure and Transparency Rules.
Eurocell plc has executed a share buyback program, purchasing 10,745 of its ordinary shares at a consistent price of 131.45 pence per share on the London Stock Exchange. This transaction results in the company’s issued share capital consisting of 100,419,062 shares, which impacts the total number of voting rights and may affect shareholder notifications under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 10,728 of its ordinary shares at a consistent price of 131.38 pence per share. This transaction, conducted through Berenberg on the London Stock Exchange, results in the company having an issued share capital of 100,429,807 shares, which will be used by shareholders to determine their interests under regulatory rules.
Eurocell plc has executed a share buyback program, purchasing 10,699 of its ordinary shares at a consistent price of 132 pence per share. This transaction, conducted through Berenberg, results in Eurocell having an issued share capital of 100,440,535 shares, with no shares held in treasury. The buyback aligns with regulatory requirements and impacts shareholders by adjusting the total number of voting rights, which is crucial for compliance with the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 10,625 of its ordinary shares at a consistent price of 133 pence per share. This transaction, facilitated by Berenberg, results in a total issued share capital of 100,451,234 shares, impacting shareholder calculations under the Financial Conduct Authority’s rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 10,444 of its ordinary shares at a price of 132.25 pence each. This transaction leaves Eurocell with a total issued share capital of 100,461,859 shares, which shareholders can use to assess their interests in the company under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 9,487 of its ordinary shares at a price of 132.11 pence per share. This transaction, conducted through Berenberg, results in the company having no shares held in treasury, with a total issued share capital of 100,472,303 shares. This move is significant for shareholders as it affects the total number of voting rights and may influence their interest calculations under the Financial Conduct Authority’s rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 9,789 of its ordinary shares at a price of 133.50 pence each. This transaction leaves the company with an issued share capital of 100,481,790 shares, which is also the total number of voting rights. This move is part of Eurocell’s ongoing strategy to manage its capital structure and may affect shareholder calculations under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback transaction, purchasing 10,002 of its ordinary shares at a price of 132.95 pence each on the London Stock Exchange. This move results in the company’s total issued share capital consisting of 100,491,579 shares, impacting the calculation of voting rights for shareholders under financial regulations.
Eurocell plc has repurchased 9,822 of its ordinary shares at a price of 131.25 pence each through its broker, Berenberg, on the London Stock Exchange. This transaction is part of the company’s Share Buyback Programme, resulting in a total issued share capital of 100,501,581 shares, which will affect shareholder voting rights calculations.
Eurocell plc has executed a share buyback program, purchasing 9,782 of its ordinary shares at a price of 131.50 pence per share on the London Stock Exchange. This transaction reduces the company’s share capital to 100,511,403 shares, impacting the number of voting rights and potentially affecting shareholder calculations under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 9,812 of its ordinary shares at a consistent price of 133 pence per share. This transaction, facilitated by Berenberg, impacts the company’s share capital, leaving no shares in treasury and setting the total voting rights at 100,521,185. This move is part of Eurocell’s strategy to manage its capital structure and could influence shareholder value and market perception.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 9,659 of its ordinary shares at a price of 131.50 pence each. This transaction results in the company’s issued share capital consisting of 100,530,997 shares, with no shares held in treasury, thereby impacting the total number of voting rights available to shareholders.
Eurocell plc has executed a share buyback program, purchasing 9,034 of its ordinary shares at a consistent price of 135.23 pence each on the London Stock Exchange. This transaction results in the company’s issued share capital consisting of 100,540,656 shares, with no shares held in treasury, impacting shareholder calculations under the Financial Conduct Authority’s rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 5,176 of its ordinary shares at a consistent price of 135 pence per share. This transaction has resulted in the company’s issued share capital consisting of 100,549,690 shares, which is significant for shareholders monitoring their voting rights and interests under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback, purchasing 5,013 of its ordinary shares at a consistent price of 133 pence per share on the London Stock Exchange. This transaction is part of the company’s Share Buyback Programme and results in a total issued share capital of 100,554,866 shares, which shareholders can use to assess their voting rights and interests in accordance with regulatory requirements.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 5,047 of its ordinary shares at a consistent price of 128 pence per share. This transaction results in Eurocell having no shares held in treasury, with a total issued share capital of 100,559,879 shares, which is also the number of voting rights available. This move may impact shareholder calculations under the Financial Conduct Authority’s Disclosure and Transparency Rules.
Eurocell plc has executed a share buyback program, purchasing 4,964 of its ordinary shares at a price of 131.50 pence each on the London Stock Exchange. This transaction leaves the company with an issued share capital of 100,564,926 shares, which will be used by shareholders to determine notification requirements under the Financial Conduct Authority’s rules.